| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.42e-05 | 188 | 103 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | opsonin binding | 2.82e-04 | 25 | 103 | 3 | GO:0001846 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 3.42e-04 | 180 | 103 | 6 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 3.74e-04 | 257 | 103 | 7 | GO:0061134 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 4.20e-04 | 187 | 103 | 6 | GO:0030414 | |
| GeneOntologyMolecularFunction | complement binding | 5.93e-04 | 32 | 103 | 3 | GO:0001848 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 6.14e-04 | 201 | 103 | 6 | GO:0061135 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | CFH PDGFRA KALRN TFPI2 GAS6 CEACAM1 TYRO3 LPA SERPINB2 UMOD WNK3 | 1.31e-05 | 442 | 103 | 11 | GO:0050878 |
| GeneOntologyBiologicalProcess | glomerular filtration | 2.15e-05 | 33 | 103 | 4 | GO:0003094 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CFH SEMA4D TARM1 PDGFRA LAMA3 CEACAM1 HAVCR2 TYRO3 TMEM47 PTPRF CNTN5 UMOD CTNND2 NODAL MUC4 CNN3 CNTN1 | 2.30e-05 | 1077 | 103 | 17 | GO:0098609 |
| GeneOntologyBiologicalProcess | innate immune response | A2M CFH TARM1 NLRX1 MUC19 SHMT2 TLR7 CREBBP CEACAM1 HAVCR2 TYRO3 TOMM70 JCHAIN UMOD C4A C4B CTSS | 2.74e-05 | 1092 | 103 | 17 | GO:0045087 |
| GeneOntologyBiologicalProcess | renal filtration | 3.05e-05 | 36 | 103 | 4 | GO:0097205 | |
| GeneOntologyBiologicalProcess | blood coagulation | 4.85e-05 | 260 | 103 | 8 | GO:0007596 | |
| GeneOntologyBiologicalProcess | coagulation | 5.69e-05 | 266 | 103 | 8 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 6.00e-05 | 268 | 103 | 8 | GO:0007599 | |
| GeneOntologyBiologicalProcess | activation of immune response | A2M CFH NLRX1 TLR7 CREBBP CEACAM1 HAVCR2 TYRO3 TOMM70 C4A C4B CTSS | 6.47e-05 | 623 | 103 | 12 | GO:0002253 |
| GeneOntologyBiologicalProcess | regulation of immune response | A2M CFH TARM1 NLRX1 LAIR2 TLR7 CREBBP CEACAM1 HAVCR2 TYRO3 TOMM70 C4A C4B IGSF1 MUC4 CTSS | 9.21e-05 | 1085 | 103 | 16 | GO:0050776 |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 9.64e-05 | 48 | 103 | 4 | GO:0043277 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 1.11e-04 | 151 | 103 | 6 | GO:0002832 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.51e-04 | 21 | 103 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.51e-04 | 21 | 103 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | parental behavior | 1.51e-04 | 21 | 103 | 3 | GO:0060746 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | A2M CFH TARM1 NLRX1 MUC19 SHMT2 TLR7 CREBBP CEACAM1 HAVCR2 TYRO3 TOMM70 JCHAIN UMOD C4A C4B CTSS | 2.04e-04 | 1286 | 103 | 17 | GO:0140546 |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | A2M PDGFRA NLRX1 MUC19 CEACAM1 LRIG2 HAVCR2 TYRO3 LPA SERPINB2 | 2.32e-04 | 509 | 103 | 10 | GO:0032102 |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | A2M CFH PDGFRA NLRX1 GAS6 MUC19 TLR7 CREBBP CEACAM1 LRIG2 HAVCR2 TYRO3 TOMM70 PTPRF LPA SERPINB2 CTSS | 2.68e-04 | 1316 | 103 | 17 | GO:0032101 |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 2.69e-04 | 114 | 103 | 5 | GO:0045824 | |
| GeneOntologyBiologicalProcess | regulation of innate immune response | 2.71e-04 | 519 | 103 | 10 | GO:0045088 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | A2M CFH NLRX1 TLR7 CREBBP CEACAM1 HAVCR2 TYRO3 TOMM70 MUC4 CTSS | 3.68e-04 | 643 | 103 | 11 | GO:0002831 |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 3.95e-04 | 69 | 103 | 4 | GO:0030195 | |
| GeneOntologyBiologicalProcess | complement activation | 4.18e-04 | 70 | 103 | 4 | GO:0006956 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 4.18e-04 | 70 | 103 | 4 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 4.26e-04 | 126 | 103 | 5 | GO:1903035 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 4.65e-04 | 72 | 103 | 4 | GO:0050819 | |
| GeneOntologyBiologicalProcess | interferon-beta production | 4.90e-04 | 73 | 103 | 4 | GO:0032608 | |
| GeneOntologyBiologicalProcess | regulation of interferon-beta production | 4.90e-04 | 73 | 103 | 4 | GO:0032648 | |
| GeneOntologyBiologicalProcess | defense response to other organism | A2M CFH TARM1 NLRX1 MUC19 SHMT2 TLR7 CREBBP CEACAM1 HAVCR2 TYRO3 TOMM70 JCHAIN UMOD C4A C4B CTSS | 5.78e-04 | 1407 | 103 | 17 | GO:0098542 |
| GeneOntologyCellularComponent | extracellular matrix | A2M COL4A2 FLG TFPI2 LAMA3 CELA2B EGFL6 LRIG2 PTPRZ1 P3H1 LPA LTBP1 SRPX MUC4 MUC6 CTSS | 1.31e-07 | 656 | 103 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | A2M COL4A2 FLG TFPI2 LAMA3 CELA2B EGFL6 LRIG2 PTPRZ1 P3H1 LPA LTBP1 SRPX MUC4 MUC6 CTSS | 1.37e-07 | 658 | 103 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | A2M COL4A2 FLG LAMA3 CELA2B EGFL6 PTPRZ1 P3H1 LPA LTBP1 SRPX MUC4 CTSS | 2.06e-06 | 530 | 103 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | symbiont cell surface | 6.39e-06 | 8 | 103 | 3 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 9.55e-06 | 9 | 103 | 3 | GO:0044217 | |
| GeneOntologyCellularComponent | actin-based cell projection | 7.06e-05 | 278 | 103 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.05e-04 | 109 | 103 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | keratohyalin granule | 2.38e-04 | 5 | 103 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | microvillus | 3.59e-04 | 123 | 103 | 5 | GO:0005902 | |
| GeneOntologyCellularComponent | endolysosome | 4.28e-04 | 30 | 103 | 3 | GO:0036019 | |
| GeneOntologyCellularComponent | adherens junction | 6.40e-04 | 212 | 103 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | blood microparticle | 7.37e-04 | 144 | 103 | 5 | GO:0072562 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.05e-03 | 10 | 103 | 2 | GO:0036156 | |
| MousePheno | abnormal lactation | 7.09e-05 | 72 | 84 | 5 | MP:0001882 | |
| MousePheno | abnormal response to infection | TFPI2 NLRX1 KDM6B CEACAM1 KPTN HAVCR2 TBC1D10C SP140L PTPRZ1 JCHAIN UMOD C4A C4B MUC4 | 8.25e-05 | 714 | 84 | 14 | MP:0005025 |
| MousePheno | abnormal response to antigen | TFPI2 NLRX1 KDM6B CEACAM1 KPTN HAVCR2 TBC1D10C SP140L PTPRZ1 JCHAIN UMOD C4A C4B MUC4 | 9.86e-05 | 726 | 84 | 14 | MP:0020000 |
| MousePheno | renal glomerular protein deposits | 1.14e-04 | 42 | 84 | 4 | MP:0020518 | |
| MousePheno | abnormal nest building behavior | 1.50e-04 | 45 | 84 | 4 | MP:0001447 | |
| MousePheno | abnormal exocrine gland physiology | 1.74e-04 | 196 | 84 | 7 | MP:0013559 | |
| MousePheno | abnormal mammary gland physiology | 1.84e-04 | 88 | 84 | 5 | MP:0001881 | |
| MousePheno | abnormal apocrine gland physiology | 1.84e-04 | 88 | 84 | 5 | MP:0013555 | |
| MousePheno | abnormal social/conspecific interaction behavior | 2.08e-04 | 421 | 84 | 10 | MP:0002557 | |
| MousePheno | abnormal response to social novelty | 2.09e-04 | 49 | 84 | 4 | MP:0020395 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 2.09e-04 | 49 | 84 | 4 | MP:0020948 | |
| MousePheno | increased anti-single stranded DNA antibody level | 2.22e-04 | 20 | 84 | 3 | MP:0004771 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 2.67e-04 | 279 | 84 | 8 | MP:0009785 | |
| MousePheno | decreased spleen germinal center size | 2.97e-04 | 22 | 84 | 3 | MP:0008484 | |
| Domain | IG | SEMA4D TARM1 PDGFRA KALRN LAIR2 CEACAM1 LRIG2 HAVCR2 TYRO3 PTPRF CNTN5 IGSF1 CNTN1 | 6.15e-07 | 421 | 104 | 13 | SM00409 |
| Domain | Ig_sub | SEMA4D TARM1 PDGFRA KALRN LAIR2 CEACAM1 LRIG2 HAVCR2 TYRO3 PTPRF CNTN5 IGSF1 CNTN1 | 6.15e-07 | 421 | 104 | 13 | IPR003599 |
| Domain | IGc2 | SEMA4D PDGFRA KALRN CEACAM1 LRIG2 TYRO3 PTPRF CNTN5 IGSF1 CNTN1 | 7.62e-07 | 235 | 104 | 10 | SM00408 |
| Domain | Ig_sub2 | SEMA4D PDGFRA KALRN CEACAM1 LRIG2 TYRO3 PTPRF CNTN5 IGSF1 CNTN1 | 7.62e-07 | 235 | 104 | 10 | IPR003598 |
| Domain | IG_LIKE | SEMA4D TARM1 PDGFRA KALRN LAIR2 CEACAM1 LRIG2 HAVCR2 TYRO3 PTPRF CNTN5 IGSF1 CNTN1 | 3.38e-06 | 491 | 104 | 13 | PS50835 |
| Domain | Ig-like_dom | SEMA4D TARM1 PDGFRA KALRN LAIR2 CEACAM1 LRIG2 HAVCR2 TYRO3 PTPRF CNTN5 IGSF1 CNTN1 | 4.40e-06 | 503 | 104 | 13 | IPR007110 |
| Domain | MacrogloblnA2_thiol-ester-bond | 9.20e-06 | 8 | 104 | 3 | IPR019565 | |
| Domain | Thiol-ester_cl | 9.20e-06 | 8 | 104 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 9.20e-06 | 8 | 104 | 3 | IPR019742 | |
| Domain | Ig_I-set | 1.11e-05 | 190 | 104 | 8 | IPR013098 | |
| Domain | I-set | 1.11e-05 | 190 | 104 | 8 | PF07679 | |
| Domain | - | SEMA4D TARM1 PDGFRA KALRN LAIR2 CEACAM1 LRIG2 HAVCR2 TYRO3 PTPRF PTPRZ1 CNTN5 IGSF1 CNTN1 | 1.83e-05 | 663 | 104 | 14 | 2.60.40.10 |
| Domain | A2M | 1.96e-05 | 10 | 104 | 3 | PF00207 | |
| Domain | A2M_N_2 | 1.96e-05 | 10 | 104 | 3 | IPR011625 | |
| Domain | A2M_comp | 1.96e-05 | 10 | 104 | 3 | IPR011626 | |
| Domain | A2M_recep | 1.96e-05 | 10 | 104 | 3 | PF07677 | |
| Domain | A2M_comp | 1.96e-05 | 10 | 104 | 3 | PF07678 | |
| Domain | A2M_N | 1.96e-05 | 10 | 104 | 3 | PF01835 | |
| Domain | A2M_N | 1.96e-05 | 10 | 104 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.96e-05 | 10 | 104 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.96e-05 | 10 | 104 | 3 | PS00477 | |
| Domain | A2M_N_2 | 1.96e-05 | 10 | 104 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 1.96e-05 | 10 | 104 | 3 | IPR001599 | |
| Domain | Ig-like_fold | SEMA4D TARM1 PDGFRA KALRN LAIR2 CEACAM1 LRIG2 HAVCR2 TYRO3 PTPRF PTPRZ1 CNTN5 IGSF1 CNTN1 | 3.65e-05 | 706 | 104 | 14 | IPR013783 |
| Domain | Ig_2 | 5.40e-05 | 73 | 104 | 5 | PF13895 | |
| Domain | VWF_type-D | 8.91e-05 | 16 | 104 | 3 | IPR001846 | |
| Domain | VWFD | 8.91e-05 | 16 | 104 | 3 | PS51233 | |
| Domain | VWD | 8.91e-05 | 16 | 104 | 3 | SM00216 | |
| Domain | VWD | 8.91e-05 | 16 | 104 | 3 | PF00094 | |
| Domain | ig | 9.34e-05 | 190 | 104 | 7 | PF00047 | |
| Domain | Immunoglobulin | 9.34e-05 | 190 | 104 | 7 | IPR013151 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.29e-04 | 18 | 104 | 3 | IPR008930 | |
| Domain | TBC | 1.59e-04 | 49 | 104 | 4 | SM00164 | |
| Domain | - | 1.59e-04 | 207 | 104 | 7 | 1.25.40.10 | |
| Domain | RabGAP-TBC | 2.15e-04 | 53 | 104 | 4 | PF00566 | |
| Domain | Rab-GTPase-TBC_dom | 2.49e-04 | 55 | 104 | 4 | IPR000195 | |
| Domain | TBC_RABGAP | 2.49e-04 | 55 | 104 | 4 | PS50086 | |
| Domain | fn3 | 2.92e-04 | 162 | 104 | 6 | PF00041 | |
| Domain | Anaphylatoxin_comp_syst | 3.04e-04 | 5 | 104 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 3.04e-04 | 5 | 104 | 2 | IPR001840 | |
| Domain | TPR-like_helical_dom | 3.27e-04 | 233 | 104 | 7 | IPR011990 | |
| Domain | FN3 | 5.92e-04 | 185 | 104 | 6 | SM00060 | |
| Domain | ANATO | 6.33e-04 | 7 | 104 | 2 | SM00104 | |
| Domain | Pept_M16_Zn_BS | 6.33e-04 | 7 | 104 | 2 | IPR001431 | |
| Domain | Pept_M16_dom | 6.33e-04 | 7 | 104 | 2 | IPR011237 | |
| Domain | Metalloenz_LuxS/M16 | 6.33e-04 | 7 | 104 | 2 | IPR011249 | |
| Domain | Peptidase_M16 | 6.33e-04 | 7 | 104 | 2 | PF00675 | |
| Domain | ANAPHYLATOXIN_2 | 6.33e-04 | 7 | 104 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 6.33e-04 | 7 | 104 | 2 | PS01177 | |
| Domain | Peptidase_M16_C | 6.33e-04 | 7 | 104 | 2 | IPR007863 | |
| Domain | ANATO | 6.33e-04 | 7 | 104 | 2 | PF01821 | |
| Domain | Peptidase_M16_C | 6.33e-04 | 7 | 104 | 2 | PF05193 | |
| Domain | Pept_M16_N | 6.33e-04 | 7 | 104 | 2 | IPR011765 | |
| Domain | - | 6.33e-04 | 7 | 104 | 2 | 3.30.830.10 | |
| Domain | INSULINASE | 6.33e-04 | 7 | 104 | 2 | PS00143 | |
| Domain | Anaphylatoxin/fibulin | 6.33e-04 | 7 | 104 | 2 | IPR000020 | |
| Domain | A2M_N_2 | 8.41e-04 | 8 | 104 | 2 | SM01359 | |
| Domain | - | 8.41e-04 | 8 | 104 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 8.41e-04 | 8 | 104 | 2 | SM01361 | |
| Domain | A2M | 8.41e-04 | 8 | 104 | 2 | SM01360 | |
| Domain | FN3 | 8.66e-04 | 199 | 104 | 6 | PS50853 | |
| Domain | FN3_dom | 1.12e-03 | 209 | 104 | 6 | IPR003961 | |
| Domain | EGF_CA | 1.36e-03 | 86 | 104 | 4 | PF07645 | |
| Domain | GFP-like | 1.63e-03 | 11 | 104 | 2 | IPR023413 | |
| Domain | - | 1.63e-03 | 11 | 104 | 2 | 2.40.155.10 | |
| Domain | Growth_fac_rcpt_ | 1.80e-03 | 156 | 104 | 5 | IPR009030 | |
| Domain | C8 | 1.95e-03 | 12 | 104 | 2 | PF08742 | |
| Domain | TIL | 1.95e-03 | 12 | 104 | 2 | PF01826 | |
| Domain | - | 1.95e-03 | 12 | 104 | 2 | 1.50.10.20 | |
| Domain | EGF | 2.03e-03 | 235 | 104 | 6 | SM00181 | |
| Domain | EGF_Ca-bd_CS | 2.11e-03 | 97 | 104 | 4 | IPR018097 | |
| Domain | EGF_CA | 2.28e-03 | 99 | 104 | 4 | PS01187 | |
| Domain | Unchr_dom_Cys-rich | 2.30e-03 | 13 | 104 | 2 | IPR014853 | |
| Domain | C8 | 2.30e-03 | 13 | 104 | 2 | SM00832 | |
| Domain | TPR_REGION | 2.30e-03 | 165 | 104 | 5 | PS50293 | |
| Domain | TPR | 2.30e-03 | 165 | 104 | 5 | PS50005 | |
| Domain | ASX_HYDROXYL | 2.36e-03 | 100 | 104 | 4 | PS00010 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.68e-03 | 14 | 104 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.68e-03 | 14 | 104 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.68e-03 | 14 | 104 | 2 | PF08393 | |
| Domain | TIL_dom | 2.68e-03 | 14 | 104 | 2 | IPR002919 | |
| Domain | ATPase_dyneun-rel_AAA | 2.68e-03 | 14 | 104 | 2 | IPR011704 | |
| Domain | AAA_8 | 2.68e-03 | 14 | 104 | 2 | PF12780 | |
| Domain | AAA_5 | 2.68e-03 | 14 | 104 | 2 | PF07728 | |
| Domain | EGF-like_dom | 2.70e-03 | 249 | 104 | 6 | IPR000742 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.92e-03 | 106 | 104 | 4 | IPR000152 | |
| Domain | EGF_1 | 3.04e-03 | 255 | 104 | 6 | PS00022 | |
| Domain | Sushi | 3.04e-03 | 52 | 104 | 3 | PF00084 | |
| Domain | DHC_fam | 3.08e-03 | 15 | 104 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 3.08e-03 | 15 | 104 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.08e-03 | 15 | 104 | 2 | IPR004273 | |
| Domain | CCP | 3.39e-03 | 54 | 104 | 3 | SM00032 | |
| Domain | EGF-like_CS | 3.41e-03 | 261 | 104 | 6 | IPR013032 | |
| Domain | EGF_2 | 3.67e-03 | 265 | 104 | 6 | PS01186 | |
| Domain | SUSHI | 3.75e-03 | 56 | 104 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 3.95e-03 | 57 | 104 | 3 | IPR000436 | |
| Domain | C345C | 3.95e-03 | 17 | 104 | 2 | SM00643 | |
| Domain | EGF_CA | 4.82e-03 | 122 | 104 | 4 | SM00179 | |
| Domain | NTR | 4.94e-03 | 19 | 104 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 4.94e-03 | 19 | 104 | 2 | IPR018933 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | A2M CFH COL4A2 GAS6 LAMA3 VTA1 CEACAM1 TBC1D10A GUSB JCHAIN CLTC UMOD C4A C4B MUC4 CRISPLD1 CNTN1 | 1.94e-08 | 1070 | 104 | 17 | 23533145 |
| Pubmed | 3.28e-08 | 162 | 104 | 8 | 25826454 | ||
| Pubmed | 8.52e-08 | 257 | 104 | 9 | 16335952 | ||
| Pubmed | 5.16e-07 | 6 | 104 | 3 | 16849499 | ||
| Pubmed | SHMT2 MYO1B NOL10 PCF11 TOMM70 PTPRF PTPRZ1 P3H1 CLTC SUPT16H LTBP1 PRPF38A MARVELD2 UQCRC2 | 3.02e-06 | 1049 | 104 | 14 | 27880917 | |
| Pubmed | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. | 4.21e-06 | 11 | 104 | 3 | 23204401 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG KALRN ZMYM2 SHMT2 MYO1B THOC5 PCF11 NWD2 CLTC SUPT16H SF3A3 SRPX PRPF38A UQCRC2 | 4.31e-06 | 1082 | 104 | 14 | 38697112 |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 8.86e-06 | 2 | 104 | 2 | 16565498 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15998580 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 8.86e-06 | 2 | 104 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 8.86e-06 | 2 | 104 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 8.86e-06 | 2 | 104 | 2 | 17645767 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 8.86e-06 | 2 | 104 | 2 | 27758680 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 8.86e-06 | 2 | 104 | 2 | 23749435 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 8.86e-06 | 2 | 104 | 2 | 3037333 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23570341 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 11726230 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 8.86e-06 | 2 | 104 | 2 | 6950384 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 8.86e-06 | 2 | 104 | 2 | 8428773 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7634325 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 8.86e-06 | 2 | 104 | 2 | 21345967 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 28537534 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2572548 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2302180 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 8.86e-06 | 2 | 104 | 2 | 18091514 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 29080553 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 8.86e-06 | 2 | 104 | 2 | 25339671 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7867073 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17728371 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6149580 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6149581 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12115608 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 3542363 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2387317 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 16908004 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7365238 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7391573 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 8.86e-06 | 2 | 104 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 8.86e-06 | 2 | 104 | 2 | 17971229 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6881182 | ||
| Pubmed | Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. | 8.86e-06 | 2 | 104 | 2 | 12163455 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 8.86e-06 | 2 | 104 | 2 | 17921792 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 8.86e-06 | 2 | 104 | 2 | 6978711 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 35898513 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 28873507 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 8.86e-06 | 2 | 104 | 2 | 6832377 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 3794341 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22785613 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 8.86e-06 | 2 | 104 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 8.86e-06 | 2 | 104 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 8.86e-06 | 2 | 104 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 8.86e-06 | 2 | 104 | 2 | 3696167 | |
| Pubmed | The TAM receptor Tyro3 regulates myelination in the central nervous system. | 8.86e-06 | 2 | 104 | 2 | 28145605 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 8.86e-06 | 2 | 104 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 8.86e-06 | 2 | 104 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 8.86e-06 | 2 | 104 | 2 | 15787745 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 30026462 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6559257 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 8.86e-06 | 2 | 104 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 8.86e-06 | 2 | 104 | 2 | 20506482 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12480675 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 26800705 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 8.86e-06 | 2 | 104 | 2 | 15390104 | |
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 8.86e-06 | 2 | 104 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 8.86e-06 | 2 | 104 | 2 | 2997024 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 16219677 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 8.86e-06 | 2 | 104 | 2 | 3624865 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21857912 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 8.86e-06 | 2 | 104 | 2 | 4514997 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 8.86e-06 | 2 | 104 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 8.86e-06 | 2 | 104 | 2 | 3167981 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7545960 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 30041577 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 8.86e-06 | 2 | 104 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 8.86e-06 | 2 | 104 | 2 | 34358307 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 11073949 | ||
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 8.86e-06 | 2 | 104 | 2 | 18360261 | |
| Pubmed | Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients. | 8.86e-06 | 2 | 104 | 2 | 28038383 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 8954722 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 8.86e-06 | 2 | 104 | 2 | 26814963 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 8132550 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2395880 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17915330 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 26814708 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6192448 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q23 | 2.17e-04 | 51 | 104 | 3 | chr8q23 | |
| GeneFamily | Immunoglobulin like domain containing | 8.73e-07 | 193 | 71 | 8 | 594 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.21e-06 | 161 | 71 | 7 | 593 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.79e-06 | 9 | 71 | 3 | 1234 | |
| GeneFamily | Fibronectin type III domain containing | 3.90e-05 | 160 | 71 | 6 | 555 | |
| GeneFamily | CD molecules|Mucins | 7.34e-05 | 21 | 71 | 3 | 648 | |
| GeneFamily | Complement system|Sushi domain containing | 3.78e-04 | 36 | 71 | 3 | 492 | |
| GeneFamily | Mitochondrial complex III: ubiquinol-cytochrome c reductase complex subunits|Apoptosome | 6.70e-04 | 10 | 71 | 2 | 642 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.09e-03 | 115 | 71 | 4 | 769 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.46e-03 | 57 | 71 | 3 | 1179 | |
| GeneFamily | Dyneins, axonemal | 1.99e-03 | 17 | 71 | 2 | 536 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.04e-03 | 21 | 71 | 2 | 813 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 9.27e-03 | 37 | 71 | 2 | 454 | |
| Coexpression | NABA_MATRISOME | A2M COL4A2 FLG SEMA4D ADAM7 GAS6 MUC19 LAMA3 CELA2B EGFL6 P3H1 LPA SERPINB2 LTBP1 SRPX NODAL MUC4 CRISPLD1 MUC6 CTSS | 3.35e-09 | 1026 | 104 | 20 | M5889 |
| Coexpression | NABA_MATRISOME | A2M COL4A2 SEMA4D ADAM7 GAS6 MUC19 LAMA3 CELA2B EGFL6 P3H1 LPA SERPINB2 LTBP1 SRPX NODAL MUC4 CRISPLD1 MUC6 CTSS | 1.50e-08 | 1008 | 104 | 19 | MM17056 |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN | 5.24e-07 | 176 | 104 | 8 | M8790 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | A2M FLG SEMA4D ADAM7 MUC19 CELA2B EGFL6 P3H1 LPA SERPINB2 NODAL MUC4 MUC6 CTSS | 1.64e-06 | 751 | 104 | 14 | M5885 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | A2M SEMA4D ADAM7 MUC19 CELA2B EGFL6 P3H1 LPA SERPINB2 NODAL MUC4 MUC6 CTSS | 7.30e-06 | 738 | 104 | 13 | MM17058 |
| Coexpression | NABA_ECM_REGULATORS | 4.69e-05 | 238 | 104 | 7 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 5.21e-05 | 242 | 104 | 7 | MM17062 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | CFH LAMA3 TLR7 CEACAM1 DNAH12 GUSB SERPINB2 C4A C4B LTBP1 CTSS | 1.01e-05 | 438 | 104 | 11 | GSM605850_500 |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 6.18e-05 | 441 | 104 | 10 | GSM605862_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_100 | 7.10e-05 | 3 | 104 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_100 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 7.72e-05 | 453 | 104 | 10 | GSM777067_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.43e-05 | 369 | 104 | 9 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 9.75e-05 | 466 | 104 | 10 | GSM777050_500 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 1.08e-09 | 200 | 104 | 9 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.14e-09 | 177 | 104 | 8 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.14e-09 | 177 | 104 | 8 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 1.24e-08 | 184 | 104 | 8 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-08 | 185 | 104 | 8 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-08 | 195 | 104 | 8 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-08 | 195 | 104 | 8 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-08 | 195 | 104 | 8 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-08 | 195 | 104 | 8 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-08 | 197 | 104 | 8 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | medial-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.37e-08 | 200 | 104 | 8 | a9d8aa5bcf383d98a9e2eaf4b1f8466982d6b088 | |
| ToppCell | 15-Airway|15 / Age, Tissue, Lineage and Cell class | 2.37e-08 | 200 | 104 | 8 | ba4b8d5becf81351901c2ecac74ffa28e29586f3 | |
| ToppCell | medial-mesenchymal|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.37e-08 | 200 | 104 | 8 | 4f19e1e40966e27779bf77e8c170ed3ecc24353e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.88e-08 | 148 | 104 | 7 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.06e-08 | 152 | 104 | 7 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | tumor_Lung-Fibroblasts-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 2.32e-07 | 181 | 104 | 7 | 53bcab4d6df4a3255d81877ba22fb95d4492ce9f | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-07 | 181 | 104 | 7 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-07 | 187 | 104 | 7 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.89e-07 | 187 | 104 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 3.00e-07 | 188 | 104 | 7 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.11e-07 | 189 | 104 | 7 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.58e-07 | 193 | 104 | 7 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.71e-07 | 194 | 104 | 7 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-07 | 195 | 104 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.84e-07 | 195 | 104 | 7 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass | 3.84e-07 | 195 | 104 | 7 | ea9ff25020c2fcd1bab80e1829af0f4e4777de8b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-07 | 195 | 104 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-07 | 196 | 104 | 7 | d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-07 | 196 | 104 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-07 | 196 | 104 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.11e-07 | 197 | 104 | 7 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.26e-07 | 198 | 104 | 7 | 1282db321e27499d310339d6383974614e295a20 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 4.26e-07 | 198 | 104 | 7 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 4.26e-07 | 198 | 104 | 7 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.26e-07 | 198 | 104 | 7 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.26e-07 | 198 | 104 | 7 | 01d563ccdc0da02dac04169e713844fecb4233a1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-07 | 198 | 104 | 7 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-07 | 198 | 104 | 7 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-07 | 198 | 104 | 7 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | (5)_Fibroblast-A_(Fibroblast_progenitors)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.40e-07 | 199 | 104 | 7 | b783917fe0a9725a680aa430a42f02ce294900ef | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.40e-07 | 199 | 104 | 7 | e9009eee7f77b9c9917f8e0e723001d9e76eb553 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.40e-07 | 199 | 104 | 7 | 04e5cfb85c681fd3f4c1151062e4a0f460b55d5f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.40e-07 | 199 | 104 | 7 | 9e32644b93fb1c4946dbe388fd5c357304d14e36 | |
| ToppCell | 368C-Fibroblasts|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.40e-07 | 199 | 104 | 7 | dbf64b83e2dc311b68f299c3f306ee098efd664c | |
| ToppCell | normal_Lung-Fibroblasts|normal_Lung / Location, Cell class and cell subclass | 4.56e-07 | 200 | 104 | 7 | 803cf7f1382d07220249029cd220233232027689 | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.56e-07 | 200 | 104 | 7 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.56e-07 | 200 | 104 | 7 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | 18-Airway-Mesenchymal|Airway / Age, Tissue, Lineage and Cell class | 4.56e-07 | 200 | 104 | 7 | aca1e8def8ed6ae5749402d0288ad90656213de1 | |
| ToppCell | 390C-Fibroblasts|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-07 | 200 | 104 | 7 | 3abe0f017fee6057ba73bd661a2bc8ec9e2bfe38 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.56e-07 | 200 | 104 | 7 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.56e-07 | 200 | 104 | 7 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.56e-07 | 200 | 104 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.56e-07 | 200 | 104 | 7 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.56e-07 | 200 | 104 | 7 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.56e-07 | 200 | 104 | 7 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | 367C-Fibroblasts|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-07 | 200 | 104 | 7 | c5aaa20c59b9f11b8abdf5de9e3fc54f4e6e39f7 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-06 | 166 | 104 | 6 | 1a3a15d1fc76bb91d832cdc6e3da0a6140b94b75 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-06 | 168 | 104 | 6 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-06 | 168 | 104 | 6 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-06 | 168 | 104 | 6 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.88e-06 | 169 | 104 | 6 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-06 | 170 | 104 | 6 | 81341bf4fe090af70b2091b6b2579ed08d76e22d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-06 | 174 | 104 | 6 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.52e-06 | 175 | 104 | 6 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.52e-06 | 175 | 104 | 6 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-06 | 176 | 104 | 6 | 5201f003192c033655ba47f0faf8c47a96eae03d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.63e-06 | 176 | 104 | 6 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.88e-06 | 178 | 104 | 6 | 30d2b54462fd16222ad2e3806be6143e834b29e0 | |
| ToppCell | IIH-matDC|IIH / Condition, Cell_class and T cell subcluster | 4.01e-06 | 179 | 104 | 6 | 5999c85ce3bab5309ff1ed154be7e32b037750b1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.01e-06 | 179 | 104 | 6 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | IIH-matDC-|IIH / Condition, Cell_class and T cell subcluster | 4.01e-06 | 179 | 104 | 6 | 46074b2781ed79e2979428b3ec81504621d3903c | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 4.14e-06 | 180 | 104 | 6 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.27e-06 | 181 | 104 | 6 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 4.27e-06 | 181 | 104 | 6 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.55e-06 | 183 | 104 | 6 | 28e1fc6498aaf8f42c4d6d4fa54ffff4c546d0d1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.55e-06 | 183 | 104 | 6 | 667d9107af17fd076ceff6b2cbcb78f892fd62d2 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.55e-06 | 183 | 104 | 6 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.69e-06 | 184 | 104 | 6 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 4.69e-06 | 184 | 104 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.84e-06 | 185 | 104 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.99e-06 | 186 | 104 | 6 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.99e-06 | 186 | 104 | 6 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.99e-06 | 186 | 104 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.99e-06 | 186 | 104 | 6 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.99e-06 | 186 | 104 | 6 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 4.99e-06 | 186 | 104 | 6 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 4.99e-06 | 186 | 104 | 6 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(2)_5-FU / Stress and Cell class | 5.15e-06 | 187 | 104 | 6 | 6bbf0f7fe203274dae8d582652f35cd3187c0065 | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 5.15e-06 | 187 | 104 | 6 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.15e-06 | 187 | 104 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 5.31e-06 | 188 | 104 | 6 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.47e-06 | 189 | 104 | 6 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.47e-06 | 189 | 104 | 6 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | normal_Lung-Fibroblasts-Undetermined|normal_Lung / Location, Cell class and cell subclass | 5.64e-06 | 190 | 104 | 6 | 30d4658bcc6796f0cdf54cc029f4bb904b13ef66 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 190 | 104 | 6 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 190 | 104 | 6 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.64e-06 | 190 | 104 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 190 | 104 | 6 | 97772e69e6f51ebffbb5433ca7b40f1048723220 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 190 | 104 | 6 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 190 | 104 | 6 | 72c2b824acdc43139e6635785df3ed3feb58ec46 | |
| Drug | isoformononetin | 3.20e-06 | 7 | 104 | 3 | CID000003764 | |
| Disease | COVID-19 (is_implicated_in) | 5.25e-05 | 21 | 103 | 3 | DOID:0080600 (is_implicated_in) | |
| Disease | Central hypothyroidism | 7.21e-05 | 4 | 103 | 2 | C0271801 | |
| Disease | arterial stiffness measurement | 7.57e-05 | 64 | 103 | 4 | EFO_0004517 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.20e-04 | 5 | 103 | 2 | DOID:3030 (is_marker_for) | |
| Disease | contactin-1 measurement | 1.79e-04 | 6 | 103 | 2 | EFO_0020286 | |
| Disease | age at diagnosis, coronary atherosclerosis measurement | 1.79e-04 | 6 | 103 | 2 | EFO_0004918, EFO_0007938 | |
| Disease | Complement deficiency disease | 2.09e-04 | 33 | 103 | 3 | C0272242 | |
| Disease | peritonitis (biomarker_via_orthology) | 2.51e-04 | 7 | 103 | 2 | DOID:8283 (biomarker_via_orthology) | |
| Disease | smoking status measurement, high density lipoprotein cholesterol measurement | 2.51e-04 | 7 | 103 | 2 | EFO_0004612, EFO_0006527 | |
| Disease | hepatitis A virus cellular receptor 2 measurement | 3.33e-04 | 8 | 103 | 2 | EFO_0008151 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 3.33e-04 | 8 | 103 | 2 | EFO_0020829 | |
| Disease | 2-hydroxystearate measurement | 4.28e-04 | 9 | 103 | 2 | EFO_0021059 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 4.61e-04 | 43 | 103 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | Thromboembolism | 7.78e-04 | 12 | 103 | 2 | C0040038 | |
| Disease | angina pectoris | 9.82e-04 | 125 | 103 | 4 | EFO_0003913 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.07e-03 | 14 | 103 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 1.35e-03 | 62 | 103 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | non-lobar intracerebral hemorrhage | 1.41e-03 | 63 | 103 | 3 | EFO_0010178 | |
| Disease | Antibody Deficiency Syndrome | 1.59e-03 | 17 | 103 | 2 | C0003257 | |
| Disease | adenosine monophosphate measurement | 1.78e-03 | 18 | 103 | 2 | EFO_0010454 | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.83e-03 | 69 | 103 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | cerebral infarction (is_marker_for) | 1.99e-03 | 19 | 103 | 2 | DOID:3526 (is_marker_for) | |
| Disease | coagulation factor measurement | 2.20e-03 | 20 | 103 | 2 | EFO_0004634 | |
| Disease | tissue factor measurement | 2.43e-03 | 21 | 103 | 2 | EFO_0010623 | |
| Disease | creatinine measurement | 2.53e-03 | 995 | 103 | 10 | EFO_0004518 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.66e-03 | 22 | 103 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Renal glomerular disease | 2.91e-03 | 23 | 103 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.91e-03 | 23 | 103 | 2 | C4521256 | |
| Disease | Immunologic Deficiency Syndromes | 2.91e-03 | 23 | 103 | 2 | C0021051 | |
| Disease | Colorectal Carcinoma | 3.23e-03 | 702 | 103 | 8 | C0009402 | |
| Disease | unipolar depression | CFH ETV5 AK9 CSMD3 ZC3H7A ZBTB34 SP140L CNTN5 CTNND2 DNAH6 CNTN1 | 3.27e-03 | 1206 | 103 | 11 | EFO_0003761 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASKNYYPKQNARDYC | 1386 | Q68DN1 | |
| KAQRLRPLYQYVNYC | 186 | Q6ZW13 | |
| PYNRRCVNTFGSYYC | 186 | Q8IUX8 | |
| ENYGYRDTVVYQCNP | 2831 | Q7Z407 | |
| FACYYPRVEYGFQVK | 1616 | P0C0L5 | |
| GSPLKAQSYEYVYRC | 411 | Q86V21 | |
| FKYNLRVPYGANYSC | 156 | Q9H2U9 | |
| KQLCTIPRDAAYYSY | 1216 | Q92793 | |
| PGDVCYYASRNDKSY | 1551 | P08572 | |
| ALQLAYYRIYGQACA | 436 | P43155 | |
| LRKCYFPYLENGYNQ | 386 | P08603 | |
| RYYATYINKDPGLCG | 4026 | P20930 | |
| ASNYADPYRQLQYCP | 496 | Q9UQB3 | |
| VRVNYKDRSPCYGYQ | 421 | P01023 | |
| YQCLAENKYGAIYAS | 456 | O94779 | |
| YCRDENSVPAAYYLR | 161 | Q9ULI1 | |
| LDTLRIYYGNGCKYN | 1046 | Q6ZS30 | |
| IYYGNGCKYNELSLD | 1051 | Q6ZS30 | |
| AYRNALANPLYCPDY | 181 | P22695 | |
| YYNIGNYTQAVECAK | 311 | Q32P28 | |
| CLNNKYSEGYPGKRY | 91 | P34897 | |
| YCFYGDLVNYLHKNR | 676 | P16234 | |
| RCDGYKGYDLVYSPQ | 5301 | Q99102 | |
| PAPFYKRCVYQACNY | 611 | Q6W4X9 | |
| NCEQCAKGYYRPYGV | 401 | Q16787 | |
| YRGCEYPNLNGLYIF | 481 | Q96JK4 | |
| VKGYYDNPKVCALYI | 196 | Q14165 | |
| IAYQGRVKDEPAYYC | 1561 | O15054 | |
| YGQELLCYKYRGPES | 331 | Q9Y664 | |
| YCKQGTYYDPVKLQC | 1451 | Q14766 | |
| RKPNLCPVYCDYYNA | 1531 | Q7Z5P9 | |
| YCQNKPRSEYIVAEY | 2021 | O60229 | |
| CNVKYAYEYLGNSPR | 1211 | Q6ZR08 | |
| QALGANYGEKCLYNY | 106 | P41161 | |
| TAYPCDSYQDYRNGK | 266 | Q8WWY8 | |
| YTRYGKCYTFNADPR | 196 | Q96FT7 | |
| YFQLRLNQPYCGYAV | 321 | Q86UT6 | |
| GTYKPRVRCYDTYQL | 71 | Q9BSC4 | |
| NYVDGYNRPKAYIAA | 1786 | P23471 | |
| KIPGYRVGCYYCLFQ | 116 | Q9HAS0 | |
| SKYIYDQCPAVAGYG | 446 | P31930 | |
| GKIYHPSCYEDYQNT | 1471 | O94913 | |
| YKCLQIELSRGYNYD | 2466 | Q9C0G6 | |
| IGNYSCSYRLQAYPD | 1221 | Q8N6C5 | |
| LGCNYYYKPSIFTRV | 241 | P08218 | |
| DTYYRPGANLSLSCY | 246 | P13688 | |
| RENLCYKEGSDRYYP | 236 | Q9H336 | |
| RYLDCINKYGSPYTK | 91 | Q14393 | |
| KGAPYVDVICLNSYY | 491 | P08236 | |
| QKDAGIYYCLASNNY | 106 | Q12860 | |
| EYYPNAGLIMNYCRN | 521 | P08519 | |
| PAYYPNAGLIKNYCR | 976 | P08519 | |
| YYPNAGLTRNYCRNP | 1426 | P08519 | |
| YVNDTNRGGLCYYPL | 311 | Q8N4S9 | |
| VRLYFGPCNSYQYRL | 461 | Q99518 | |
| LYRSGVYYEPSCTQN | 261 | P25774 | |
| CEYLNAYSGRKYQAD | 181 | Q9BU64 | |
| YDRNKCYTAVVPLVY | 126 | P01591 | |
| YCQQYAEVKYTQGGL | 191 | Q15006 | |
| YPVKKCQERDFQYGY | 96 | Q4AE62 | |
| FACYYPRVEYGFQVK | 1616 | P0C0L4 | |
| VSEGNAGLYRCLYYK | 91 | Q6ISS4 | |
| DQYQLCYRAALEYLG | 1886 | P10586 | |
| YIRLCQKYYSSEPQA | 141 | P05120 | |
| GRAYYLQLCTSAYKQ | 146 | Q8N9W8 | |
| QGYCPVTYKDGNQRY | 1726 | Q5TCS8 | |
| VISCGYKISRNYYSP | 176 | P34981 | |
| IYPKQYNAYRCEGEC | 266 | Q96S42 | |
| YRAEVGQNAYLPCFY | 26 | Q8TDQ0 | |
| SEGLKLYYNPYTGCI | 341 | Q149N8 | |
| NQSECRKIYRYDGIY | 26 | Q8IXF0 | |
| FFYNCYKGYLPRQCL | 751 | Q92854 | |
| DVYCRAPQGGYYKTA | 66 | P78539 | |
| PYYYYIREACQGLKE | 496 | Q9H930 | |
| VEGDYTYLRINFYCP | 561 | Q9Y5B9 | |
| ENPYYDSRVVGKYCE | 896 | Q00610 | |
| YGLGRQVYDPKYCAA | 261 | Q15417 | |
| QYYAYTQFCLPGSAR | 256 | Q9NUD9 | |
| GYQAPYFLTVCKPNY | 201 | Q7Z2D5 | |
| SVQVKACAGGYYVYN | 261 | P07911 | |
| AYAYRNPKIGYCQAM | 561 | Q0IIM8 | |
| RAQKYCKYAGSALQY | 271 | Q9NP79 | |
| AYTLYRPEQGYCQAQ | 166 | Q8IV04 | |
| YICVKAGRNPNYGYT | 351 | Q99250 | |
| KFPRCAEGYALYAQA | 471 | O94826 | |
| GAILYCLNPKNYEDY | 166 | Q9BQJ4 | |
| GTAIDCYKYLEPLYN | 111 | Q8NAV1 | |
| ILYLGQNCYYRNPCY | 176 | Q9NYK1 | |
| PYECKQCGKAFRYYQ | 251 | Q8N972 | |
| KACNNYQYGYLAKPD | 101 | Q8IYB0 | |
| NYAPDSIYYLCLGIQ | 1136 | Q9UBW7 | |
| KTNYEGPYYICKDVA | 496 | Q8IWR0 | |
| TGEKPYQCQYCEYRS | 571 | P17010 | |
| SNRQKTPYEGNYYKC | 316 | Q5JVG2 | |
| YNDNFFGLYCICKRP | 126 | Q8N806 | |
| YNCEICGNYTYRGPK | 406 | Q12874 | |
| LCSANVTRYYFNPRY | 166 | P48307 | |
| LCRQNNLYVQPYACY | 516 | Q8N584 | |
| NLYVQPYACYELGCL | 521 | Q8N584 | |
| RDPGRDYELYKYTCQ | 46 | Q13769 | |
| CPEYLVDYLENYGRK | 191 | O75604 | |
| YTLYRPEEGYCQAQA | 186 | Q9BXI6 | |
| DARRCYLYYFKSPQD | 61 | Q9UPU7 | |
| YSGDYYRQGCASKLP | 681 | Q06418 | |
| NLKVRNAGEYTCEYY | 86 | B6A8C7 | |
| NAGEYTCEYYRKASP | 91 | B6A8C7 | |
| YPYNERLICIYCGKS | 366 | Q8NCN2 | |
| LYNKGEALYGYCNLK | 171 | Q96H79 | |
| YPYSECQNAAQIYRK | 346 | Q9BYP7 | |
| YDNANIYSRTREYCP | 906 | O94898 | |
| GYAFRQAYEPCLERY | 631 | O43795 |